Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test
- 22 January 2002
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 436 (3) , 197-205
- https://doi.org/10.1016/s0014-2999(01)01628-4
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversionNature, 2000
- Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the ratEuropean Journal of Pharmacology, 1999
- The Bed Nucleus of the Stria Terminalis: A Target Site for Noradrenergic Actions in Opiate WithdrawalAnnals of the New York Academy of Sciences, 1999
- Rationale for the development of noradrenaline reuptake inhibitorsHuman Psychopharmacology: Clinical and Experimental, 1998
- Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depthBehavioural Brain Research, 1995
- Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressantsPsychopharmacology, 1995
- Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neuronsPsychopharmacology, 1991
- DSP-4 treatment produces abnormal tyrosine hydroxylase immunoreactive fibers in rat hippocampusExperimental Neurology, 1988
- Is the forced swimming test a suitable model for revealing antidepressant activity?Psychopharmacology, 1988
- Dissociable effects of lesions to the dorsal or ventral noradrenergic bundle on the acquisition, performance, and extinction of aversive conditioning.Behavioral Neuroscience, 1987